Former Incyte CEO Buys Slumping Nektar Shares

Nektar Therapeutics director Roy A. Whitfield, who is also a former chairman and chief executive of Incyte, bought $290,200 in Nektar shares last week.
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>